Dean's Award for Innovation and Enterprise
Eligibility: Individuals and team are eligible for nomination. Teams may include co-inventors of patents, technologies, or platforms; co-founders of start-ups, spin-offs, or translational initiatives; and cross-disciplinary, clinical, or academic-industry partnerships that advance innovation, commercialisation, and enterprise outcomes.
Criteria: Nominees are evaluated based on three pillars, which together reflect not only what is achieved, but also how it is achieved and who it is achieved with.
- Innovation Impact (50%) – Demonstrates tangible outcomes that deliver real-world impact through the development of novel technologies, platforms, or intellectual property with strong translational potential, supported by achievements in patenting, licensing, or the creation of spin-off or start-up companies. Success factors include measurable clinical, societal, or economic benefits, as well as the ability to secure enterprise or translational funding.
- Innovation Culture & Influence (30%) – Demonstrates a strong commitment to fostering a culture of innovation and entrepreneurship at LKCMedicine by actively mentoring and supporting colleagues, students and junior investigators in enterprise activities, while serving as an exemplary role model in translational research and entrepreneurship.
- Collaboration & Partnerships (20%) – Demonstrates the ability to lead collaborations that advance innovations towards application, adoption, and commercialisation through cross-disciplinary partnerships and engagement with healthcare institutions, industry, government agencies, and accelerators. Success is evidenced by collaborations that enable technology development, patenting, licensing, spin-offs, pilot deployments, and the alignment of diverse stakeholders to translate innovations into real-world impact.
Submit nomination HERE
Nominations close on 30 September 2026